BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
53 hedge funds and large institutions have $928K invested in BRAINSTORM CELL THERAPUTC in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
83% less call options, than puts
Call options by funds: $149K | Put options by funds: $888K
93% less capital invested
Capital invested by funds: $14.1M → $928K (-$13.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
53
Holding in Top 10
–
Calls
$149K
Puts
$888K
Top Buyers
| 1 | +$40.7K | |
| 2 | +$40.5K | |
| 3 | +$19.4K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$8.06K |
| 5 |
Millennium Management
New York
|
+$7.58K |
Top Sellers
| 1 | -$1.46M | |
| 2 | -$1.04M | |
| 3 | -$362K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$226K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$139K |